Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Medtronic
Express Scripts
Moodys
Merck

Last Updated: March 21, 2023

Litigation for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


US Court Litigation for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,043,230 See Plans and Pricing See Plans and Pricing 2020-01-14 2020-01-28 15:0002 Antitrust Litigation District Court, S.D. Florida Plaintiff See Plans and Pricing
6,043,230 See Plans and Pricing See Plans and Pricing 2016-07-06 2018-04-25 Court of Appeals for the Federal Circuit See Plans and Pricing
6,043,230 See Plans and Pricing See Plans and Pricing 2019-05-14 15:1 Antitrust Litigation District Court, N.D. California Both See Plans and Pricing
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,922,695 Mylan Pharmaceuticals Inc. See Plans and Pricing 2014-06-04 06-04-2014 Gilead Sciences, Inc. Inter partes review See Plans and Pricing 12-09-2014 MURTY ARIMILLI See Plans and Pricing
5,935,946 MYLAN PHARMACEUTICALS INC. See Plans and Pricing 2014-06-04 06-04-2014 Gilead Sciences, Inc. Inter partes review See Plans and Pricing 12-17-2014 JOHN MUNGER See Plans and Pricing
5,977,089 Mylan Pharmaceuticals Inc. See Plans and Pricing 2014-06-04 06-04-2014 Gilead Sciences, Inc. Inter partes review See Plans and Pricing 12-09-2014 MURTY ARIMILLI See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Moodys
McKesson
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.